Stockscreener 앱 받기
154.33
0.62%
-0.96
시장 영업 전:
155.94
1.61
+1.04%
전일 마감가:
$155.29
열려 있는:
$155.37
하루 거래량:
543.64K
Relative Volume:
0.76
시가총액:
$17.23B
수익:
$9.35B
순이익/손실:
$840.00M
주가수익비율:
23.17
EPS:
6.66
순현금흐름:
$875.00M
1주 성능:
-1.02%
1개월 성능:
+2.35%
6개월 성능:
+12.34%
1년 성능:
+15.25%
1일 변동 폭
$154.00
$156.24
1주일 범위
$153.55
$157.44
52주 변동 폭
$123.04
$160.95
퀘스트 다이아그노스틱스 Stock (DGX) Company Profile
명칭
Quest Diagnostics Inc
전화
(973) 520-2700
주소
500 PLAZA DRIVE, SECAUCUS
퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-28 | 재개 | Evercore ISI | In-line |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-29 | 개시 | Piper Sandler | Neutral |
| 2023-05-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-01-23 | 개시 | Evercore ISI | In-line |
| 2022-11-17 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-04-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-04 | 업그레이드 | UBS | Neutral → Buy |
| 2021-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-07-29 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-09 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-04-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-03-18 | 재개 | Credit Suisse | Neutral |
| 2019-01-31 | 다운그레이드 | Argus | Buy → Hold |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스
New York State Teachers Retirement System Trims Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
DGX (Quest Diagnostics) PE Ratio : 20.87 (As of Nov. 02, 2024) - GuruFocus.com
Quest Diagnostics Inc. stock rises Friday, still underperforms market - MarketWatch
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by State of Alaska Department of Revenue - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Holdings Lowered by Assenagon Asset Management S.A. - MarketBeat
Quest Diagnostics (NYSE:DGX) Upgraded at StockNews.com - MarketBeat
Quest Diagnostics' SVP sells shares worth $278,525 By Investing.com - Investing.com Canada
Quest Diagnostics' SVP sells shares worth $278,525 - Investing.com India
abrdn plc Has $71.50 Million Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock rises Tuesday, still underperforms market - MarketWatch
Quest Diagnostics (NYSE:DGX) PT Raised to $165.00 - MarketBeat
DekaBank Deutsche Girozentrale Has $115.62 Million Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Director Gregg Vicky B increased direct ownership by 0.42% to 18,045 units (SEC Form 4) - Quantisnow
SVP & Chief Commercial Officer Delaney Mark E increased direct ownership by 0.08% to 5,023 units (SEC Form 4) - Quantisnow
Quest Diagnostics Incorporated (NYSE:DGX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance
FY2025 EPS Forecast for Quest Diagnostics Reduced by Analyst - MarketBeat
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Raymond James & Associates Purchases 14,899 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Mizuho Boosts Quest Diagnostics (NYSE:DGX) Price Target to $174.00 - MarketBeat
Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat (NYSE:DGX) - Seeking Alpha
Quest Diagnostics (NYSE:DGX) Stock Rating Upgraded by Baird R W - MarketBeat
Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, Amedisys and Addus HomeCare - Yahoo Finance
Quest Diagnostics to launch avian flu testing this month By Investing.com - Investing.com Canada
Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - Yahoo Finance
Quest Diagnostics (NYSE:DGX) Cut to Hold at StockNews.com - MarketBeat
Ord Minnett rates SHL as Lighten - Marketscreener.com
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
My Quest Story – Martha Baer - StockTitan
Quest upgraded to outperform by Baird, sector momentum cited - MSN
Quest Diagnostics (NYSE:DGX) Sets New 12-Month High After Strong Earnings - MarketBeat
UBS Group Boosts Quest Diagnostics (NYSE:DGX) Price Target to $166.00 - MarketBeat
Quest Diagnostics stock hits 52-week high of $159.46 By Investing.com - Investing.com Canada
Quest Diagnostics (NYSE:DGX) Releases Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Quest Diagnostics set to launch a rapid lab test to detect avian influenza A H5 virus - Seeking Alpha
Quest Diagnostics Incorporated (NYSE:DGX) Q3 2024 Earnings Call Transcript - Insider Monkey
US lab operator Quest Diagnostics to launch bird flu test at end of October - Reuters.com
Quest Diagnostics (NYSE:DGX) Rating Increased to Outperform at Robert W. Baird - MarketBeat
Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development - PR Newswire
Quest Diagnostics: Q3 Earnings Snapshot - The Advocate
Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E - Simply Wall St
Quest Diagnostics Inc (DGX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Quest Diagnostics Thrives With Strong Demand Pushing Profit Above Expectations - Finimize
Earnings call: Quest Diagnostics reports robust Q3 growth, eyes M&A By Investing.com - Investing.com Canada
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday - MSN
Quest Diagnostics (NYSE:DGX) Shares Gap UpShould You Buy? - MarketBeat
Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025 - Benzinga
Quest Diagnostics (NYSE:DGX) Releases FY 2024 Earnings Guidance - MarketBeat
Quest Diagnostics beats quarterly results estimates on diagnostic test demand - Reuters
Quest Diagnostics (DGX) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance
Copeland Capital Management LLC Increases Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
퀘스트 다이아그노스틱스 (DGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.73%
0.03%
자본화:
|
볼륨(24시간):